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Background: Diabetic foot is a serious condition in patients with a long lasting diabetes mellitus. Diabetic foot
treated improperly may lead not only to delayed ulceration healing, generalized inflammation, unnecessary surgical
intervention, but also to the lower limb amputation. The aim of this study was to compare diabetic foot risk factors
in population with type 2 diabetes and risk factors for diabetes in healthy subjects.
Methods: The study included 900 subjects: 145 with diabetic foot, 293 with type 2 diabetes without diabetic foot
and 462 healthy controls matched in terms of mean age, gender structure and cardiovascular diseases absence.
Study was conducted in Gastroenterology and Metabolic Diseases Department, Medical University of Warsaw,
Poland. In statistical analysis a logistic regression model, U Mann-Whitney’s and t-Student test were used.
Results: The binomial logit models analysis showed that the risk of diabetic foot in patients with type 2 diabetes
was decreased by patient’s age (odds ratio [OR] = 0.94; 95% confidence interval [CI]: 0.92-0.96; p = 0.00001) and
hyperlipidaemia (OR = 0.54; 95% CI: 0.36-0.81; p = 0.01). In contrast, male gender (OR = 2.83; 95% CI: 1.86-4.28;
p = 0.00001) diabetes duration (OR = 1.04; 95% CI: 1.03-1.06; p = 0.0003), weight (OR = 1.04; 95% CI: 1.03-1.06;
p = 0.00001), height (OR = 1.08; 95% CI: 1.05-1.11; p = 0.00001) and waist circumference (OR = 1.028; 95% CI:
1.007-1.050; p = 0.006) increase the risk of diabetic foot. The onset of type 2 diabetes in healthy subjects was
increased by weight (OR = 1.035; 95% CI: 1.024-1.046; p = 0.00001), WC (OR = 1.075; 95% CI: 1.055-1.096; p = 00001),
hip circumference (OR = 1.03; 95% CI: 1.01-1.05; p = 0.005), overweight defined with body mass index (BMI) above
24,9 kg/m2 (OR = 2.49; 95% CI: 1.77-3.51; p = 0.00001) and hyperlipidaemia (OR = 3.53; 95% CI: 2.57-4.84; p = 0.00001).
Conclusions: Risk factors for Type 2 diabetes and diabetic foot are only partially common. Study proved that
patients who are prone to developing diabetic foot experience different risk factors than patients who are at risk of
diabetes. Identification of relationship between diabetic foot and diabetes risk factors in appropriate groups may
help clinicians to focus on certain factors in diabetic foot prevention.
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The diabetic clinics’ registers data shows that type 2 dia-
betes is present in 5.37% of adult population, however
detail epidemiological studies conducted in several re-
gions of Poland suggest twice as high frequency [1]. It
means, that very similar number of individuals is un-
aware of having diabetes. As a result, there is a large* Correspondence: piotr.nehring@gmail.com
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diabetes complications (e.g. diabetes foot) are already
present. According to Abouaesh et al. diabetic foot is
present in 15% of general population with diabetes and
it is estimated that it affects 2-12.1% of patients with
type 2 diabetes [2,3].
Diabetic foot is a long lasting diabetes complication
developing upon the presence of neuropathy and periph-
eral arterial disease (PAD) as basic etiological factors [4].
The sensorial nerve fibers damage results with the im-
paired sensation of pain, temperature and vibration leadingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and wound as a consequence. Motor neuropathy results
in loss of foot muscles function, that leads to deformation
in foot shape and increases the risk of injury. The charac-
teristic triad: neuropathy, deformation and injury is
present in 60% of patients [5]. The recurrence ratio is very
high, affecting 25-80% of patients with type 2 diabetes per
year [6].
Several studies showed 15-46 fold higher lower limb
amputation risk (LLA) in patients with diabetes in com-
parison with general population. Moreover, the neur-
opathy as a consequence of long lasting diabetes, is a
cause of 50-70% of non-traumatic LLA [3,7]. According
to Mayfield et al. studies, the odds of LLA in patients
with three or four risk factors (neuropathy, PAD, foot
bones deformation and foot wound history) are 9 times
higher comparing to patients with only one risk factor
[8]. Moreover, an amputation increases the risk of subse-
quent LLA and mortality of patients. Mortality within
the first month after LLA is 8.5% of patients, and in
5 year period reaches 39-68% [9]. Furthermore, the dia-
betic foot treatment expenses absorb about 15% of over-
all hospital budget for diabetes [3].
The aim of this study was to compare diabetic foot
risk factors in population with type 2 diabetes and risk
factors of diabetes in healthy subjects.
Methods
The study was conducted in Gastroenterology and
Metabolic Diseases Department, Medical University of
Warsaw, Poland. The study included 900 individuals:
145 patients with diabetic foot, 293 with type 2 dia-
betes without diabetic foot and 462 healthy control
subjects. The control group consisted of randomly se-
lected individuals, matched with age, gender structure
and lack of cardiovascular conditions. The proportionTable 1 Characteristics of the studied group
Diabetic foot Missing
data n/N
Total number 145 0/145
Female/male, % 34/66 0/49; 0/96
Mean age, y ± SD
Male 72.42 ± 10.46 3/96
Female 69.65 ± 11.53 2/49
Mean diabetes duration, y ± SD 15.79 ± 9.99 4/145
Mean weight, kg ± SD 93.09 ± 17.40 18/145
Mean height, cm ± SD 171.92 ± 8.58 25/145
Mean body mass index, kg/m2 ± SD 32.36 ± 5.35 7/145
Mean waist circumference, cm ± SD 111.10 ± 13.89 65/145
Mean hip circumference, cm ± SD 110.92 ± 12.07 64/145of healthy controls per one patient with diabetic foot
was 3.19:1. All patients underwent an examination
with a survey designed by authors. Diabetic foot was
diagnosed according to Global consensus guidelines on
the management and prevention of the Diabetic Foot
criteria, as an a wound, infection and/or deep foot tis-
sues destruction localized in lower limb below the ankle
in patients with diabetes complicated with neuropathy
and/or PAD [10].
The diabetic foot type was defined with detailed phy-
sical examination of superficial sensation impairment.
Neuropathy was evaluated using Thermo-tip (tempe-
rature), monofilament (touch), Neuro-tip (pain) and
Semmens-Weinstein pitchfork (vibration). The pres-
ence of pulse was assessed on dorsal pedis and tibial
posterior arteries. Each patient was qualified accord-
ing to ankle-brachial index (ratio of the blood pres-
sure in the lower legs to the blood pressure in the arms
assessed with a typical sphygmomanometer and a blind
Doppler, Bidop ES-100 V3, Hadeco Inc., Kawaski, Japan.)
and referred to ultrasound Doppler or to a vascular sur-
geon consultation if necessary. When a painless ulceration
was present, a diabetic foot of neuropathic origin was
diagnosed. The criteria of hyperlipidaemia were hiper-
cholesterolaemia, hipertrigliceridaemia or lipid-lowering
medications intake. Individuals with dominating angio-
pathic etiology of diabetic foot were disqualified from
the study. The statistical analysis was performed with
the use of logistic regression models, U Mann–Whitney
and t-Student tests with STATISTICA 9PL (StatSoft,
Inc.) software. The anthropometric features of type 2
diabetes patients and healthy control groups were previ-
ously presented in the article on the same population in
Polish Archives of Internal Medicine [11]. Missing data









293 0/293 462 0/462
59/41 0/173; 0/120 52/48 0/239; 0/223
57.35 ± 6.45 4/120 62.11 ± 10.63 0/223
58.87 ± 6.78 10/173 64.92 ± 11.95 0/293
12.28 ± 8.95 15/293 N/A N/A
80.72 ± 16.82 12/293 73.08 ± 13.44 0/462
165.48 ± 9.32 8/293 165.69 ± 8.62 0/462
29.93 ± 5.83 15/293 26.58 ± 4.20 1/462
104.55 ± 17.25 197/293 91.62 ± 11.81 4/462
108.47 ± 12.74 197/293 105.00 ± 9.72 20/462
Table 2 Factors decreasing the risk of diabetic foot in type 2 diabetes population (p < 0.05)
Studied groups Diabetic foot Missing data n/N Type 2 diabetes without diabetic foot Missing data n/N
Mean age, y 62.97 ± 11.12 5/145 71.27 ± 11.00 14/293
Hyperlipidaemia, % 40.43 (57/141) 4/145 55.88 (152/272) 21/293
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Diabetic foot risk factors in type 2 diabetes patients
The characteristics of the study groups are presented
in Table 1. The logistic regression analysis showed
that protecting factor against diabetic foot occurrence
in type 2 diabetic population was patients age and hyper-
lipidaemia (mean 62.97 v 71.27 years, OR = 0.94, 95% CI:
0.92-0.96, p = 0.00001 and OR = 0.54, 95% CI: 0.36-0.81,
p = 0.01 respectively). (Table 2).
The presence of diabetic foot was increased by male
gender (OR = 2.83, 95% CI: 1.86-4.28, p = 0.00001),
duration of diabetes (mean 15.83 v 12.27 years, OR =
1.04, 95% CI: 1.03-1.06, p = 0.0003), weight (mean
93.01 v 80.72 kg, OR = 1.04, 95% CI: 1.03-1.06, p =
0.00001), height (mean 172.01 v 165.48 cm, OR =
1.08, 95% CI: 1.05-1.11, p = 0.00001) and WC (mean
111.15 v 104.55 cm, OR = 1.028, 95% CI: 1.007-1.050,
p = 0.006) (Figure 1).
Risk factors for type 2 diabetes in a general population
In the presented study, the comparison between type 2
diabetes group and healthy subjects showed that factors
increasing the risk of diabetes were weight (mean 80.72 v
73.09 kg, OR = 1.035, 95% CI: 1.024-1.046, p = 0.00001),
WC (mean 104.55 v 91.62 cm, OR = 1.075, 95% CI: 1.055-
1.096, p = 0.00001), hips circumference (mean 108.47 v
105.00 cm, OR = 1.03, 95% CI: 1.01-1.05, p = 0.005),
overweight defined as BMI over 24.9 kg/m2 (OR = 2.49,














Figure 1 The gender structure of patients with diabetic foot and typeIn addition, the presence of hyperlipidaemia increased
the risk of type 2 diabetes in comparison to healthy
controls (OR = 3.53, 95% CI: 2.57-4.84, p = 0.00001)
(Table 3).
Discussion
The outcome of this study contributes to developement
of knowledge about the risk factors for diabetic foot in
Polish population with type 2 diabetes. This findings
may be helpful in clinical practice to identify individuals
prone to development of diabetic foot. Our study showed
that tall men with type 2 diabetes are at high risk of
diabetic foot. The increased incidence of diabetes com-
plications in men was also presented in the study con-
ducted by Simon et al., who indicated 1.4-fold increased
prevalence of diabetes complications among men compar-
ing to woman [12,13]. Our results concerning the risk of
diabetic foot associated with patient’s height are similar to
findings described by Sosenko et al. [14]. This effect is
probably related to increased risk of demyelination pro-
cess in tall patients, comparing to individuals with shor-
ter lower limbs nerve fibers. The correlation of diabetes
duration and diabetic foot risk is corresponding with
studies performed by several authors, e.g. Ashok et al.
[14-20]. According to Al-Maskari's studies the risk of
neuropathy is increased after 10-12 years of type 2 dia-
betes duration [13].
Very important finding in our study is the existence of

















type 2 diabetes healthy controls
BMI >24.9kg/m2
BMI <24.9kg/m2
Figure 2 Number of BMI over and below 24.9 kg/m2 in patients with type 2 diabetes and in healthy controls.
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weight and waist circumference length increases both
diabetic foot and type 2 diabetes occurrence risk. Pre-
sented results are in correspondence with Boyko et al.
studies, who described that the risk of diabetic foot in-
creases when patient's weight is 20 kg higher than opti-
mal body weight [4].
The results of this study demonstrates that waist and
hip circumference, overweight and hyperlipidaemia in-
creases the odds of type 2 diabetes in general population
what is in correspondence with other studies [21,22].
Dehghan et al., demonstrates that important diabetes
risk factors are BMI (over 25 kg/m2) and hip circumfer-
ence (over 102 cm in men and over 88 cm in women)
[21]. Haffner et al. indicates that type 2 diabetes risk fac-
tors are age, male sex, BMI (over 27.7 kg/m2), waist-hip
ratio over 0.825 in women and over 0.938 in men [22].
Other studies show correlation between metabolic con-
trol of diabetes and the incidence of neuropathy, diabetic
foot and even LLA [14,16-18,20,23].
Worthy notice are Booy et al. studies, showing no cor-
relation between the risk of neuropathy in type 2 diabetes
patients and the frequency of hyperlipidaemia, hyperten-
sion or smoking [24]. The presented study confirms noTable 3 Risk factors of type 2 diabetes in general population
Type 2 diabetes without diabetic foo
Mean weight, kg 80.72 ± 16.82
Mean waist circumference, cm 104.55 ± 17.25
Mean hips circumference, cm 108.47 ± 12.74
Mean BMI > 24.9 kg/m2, % 79.00 (222/281)
Hyperlipidaemia, %, (n/N) 55.88 (152/272)correlation with higher incidence of diabetic foot in popu-
lation with hyperlipidaemia.
The strength of our study is a consistence of two se-
parate control groups (individuals with uncomplicated
type 2 diabetes and healthy controls). Strict controls
matching with cases due to anthropometric and clinical
features was very important. The limitation of this study
is lack of division on neuropathic and mixed type of dia-
betic foot, however, individuals with dominating ische-
mic etiology were excluded.
There is a need to investigate the subject of diabetic
foot risk factors in more numerous study groups and to
extend it on other populations.
Conclusions
It is possible to indicate common factors influencing dia-
betic foot and diabetes frequency that are part of the
etiopathogenetic process. There are also factors that spe-
cifically increase risk of either type 2 diabetes or diabetic
foot after the occurrence of diabetes. The study also
showed the existence of independent prognostic factors
for diabetic foot that are unrelated to type 2 diabetes risk
factors of high importance in population with actually
developed diabetes.(p < 0.05)
t Missing data n/N Healthy controls Missing data n/N
12/293 73.08 ± 13.44 0/462
197/293 91.62 ± 11.81 4/462
197/293 105.00 ± 9.72 20/462
12/293 60.22 (278/467) 0/462
21/293 26.35 (122/462) 0/462
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